EcoR1 Capital, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Eton Pharmaceuticals, Inc. Common Stock (ETON)

Filing Manager
EcoR1 Capital, LLC
Reporting Manager
EcoR1 Capital, LLC
Symbol
ETON
Shares outstanding
25,727,312 shares
Disclosed Ownership
1,981,003 shares
Ownership
7.7%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 13:04:31 UTC
Date of event
31 Dec 2024

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
EcoR1 Capital, LLC 7.7% 1,981,003 0 1,981,003 /s/ Oleg Nodelman Manager
Oleg Nodelman 7.7% 1,981,003 0 1,981,003 /s/ Oleg Nodelman Reporting person
EcoR1 Capital Fund Qualified, L.P. 7.2% 1,864,034 0 1,864,034 /s/ Oleg Nodelman Manager of the General Partner, EcoR1 Capital, LLC